In hepatocellular carcinoma, miR-124 can decrease AQP3 expression, inhibiting cell proliferation and migration [60], while miR-1271-5p can prevent hepatitis B-virus-mediated liver cancer growth in vivo by decreasing the expression of AQP5 [187]. Here, AQP3 is linked to hepatocellular carcinoma.